Bioequivalence Assessment of an Oral Fixed‐Dose Formulation of Dutasteride‐Tamsulosin 0.5 mg/0.4 mg: A Randomized, Single‐Blind, Single‐Dose, 2‐Period Crossover Study in Mexican Population Under Fasted Conditions

The aim of the present study was to compare the bioavailability and to demonstrate the bioequivalence between a dutasteride‐tamsulosin 0.5 mg/0.4 mg capsule formulation and the regulatory reference drug (Combodart®, GlaxoSmithKline). A randomized, single‐blind, single‐dose, 2‐way crossover study und...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical pharmacology in drug development 2022-03, Vol.11 (3), p.318-323
Hauptverfasser:	Piñeyro‐Garza, Everardo, Gómez‐Silva, Magdalena, Gamino, María E., Delgado‐Roche, Livan
Format:	Artikel
Sprache:	eng
Schlagworte:	Bioavailability Bioequivalence Drug dosages Drug therapy dutasteride generics tamsulosin
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!